Merck COVID Pill Makes Moderna Vaccine Stock Drop

Pres. Biden's vax mandates could be irrelevant

Paid subscribers fund my independent journalism.

Merck announced at 6 a.m. on Friday that its oral COVID treatment cut hospitalization or death by half in clinical trials. When the market opened at 9:30 a.m., stock in Moderna started dropping from 358.33. One hour later, the pharmaceutical company that makes mRNA vaccines saw its stock lose 10% value.

I…